Japans Nabtesco to MassProduce AllElectric Power Steering for EV Buses MongoDB Q1 Preview Wedbush Sees Upside on Atlas Growth and AI Momentum Meta to Invest Up to 65 Billion in AI and Data Center Expansion Signaling SectorWide Acceleration Norway Doubles Down on Oil and Gas as Europe Scrambles for Supply Professional Title DuPont Announces Reverse Stock Split What It Could Mean for the Stock UK Intelligence Chief Warns of Looming Geopolitical Threats Raising Investor Caution Illinois Tool Works ITW Q1 2026 Earnings EPS Beats Estimates as Operational Strength Drives Modest Share Gain NOVTU Q1 2026 Earnings Tangible Equity Units Beat EPS Estimates Amid Limited Revenue Disclosure Biomerica Inc BMRA Q1 2026 Earnings Negative EPS Persists Amid PreRevenue Stage GASS Q4 2025 Earnings EPS Beats Estimates Stock Declines on Mixed Sentiment VRTS Q1 2026 Earnings EPS Misses Estimates on Negative Surprise HBT Financial Inc Q1 2026 Earnings EPS Falls Well Below Estimates Stock Drops CryoCell International CCEL Holds Near Support Amid Quiet Trading FACT II Acquisition Corp FACT Holds Steady at 1066 Amidst Flat Trading Session Eureka Acquisition Corp EURK Trading in a Tight Range Near 115 Support and Resistance Levels in Focus TTM Technologies TTMI Faces Sharp Decline Amid Sector Headwinds Key Support Levels in Focus WiMi Hologram Cloud Slips Slightly as Stock Hovers Near Key Support Levels Consumer Credit Growth Accelerates in December MarketWatch Report PRA Group Inc PRAA Q1 2026 Earnings EPS Surprises to the Upside Amid Limited Revenue Detail James River Group JRVR Holds Near Key Support After Marginal Uptick Dillards Capital Trust I DDT Holds Steady Near Key Support Levels Toast Inc TOST Rises 521 as Positive Momentum Builds Toward Key Resistance Horizon Technology Finance HRZN Sees Modest Uptick Holds Above Key Support Xenetic Biosciences XBIO Edges Lower Amid Tight Trading Range Orion Properties ONL Slips 167 as Office REITs Face Continued Pressure Microchip Technology Preferred Shares MCHPP Rally 448 as Market Sentiment Improves Xeris Biopharma XERS Declines 298 as Stock Tests Key Support Levels